The United States Patent and Trademark Office’s (USPTO) Office of the Chief Economist released a report revealing that small companies and universities led the way in developing inventions to diagnose COVID-19, as evidenced by patent applications filed at the USPTO through April 2023.
The U.S. federal government helped spur this invention, with 10.7% of COVID-19 diagnostic public filings receiving support. The National Institutes of Health provided the most assistance (about 64%), while the National Science Foundation provided the second most, at 21.59%. Although COVID-19 diagnostic invention was highly concentrated in a few technologies, 8.6% of these inventions were also applicable to the treatment of COVID-19. Among 5,585 global COVID-19 diagnostic patent families found in this study, 47% have at least one filing at the China National Intellectual Property Administration (CNIPA), the most of any jurisdiction.
The recent changes to Russia's intellectual property laws have made it more important than ever…
The Eurasian Patent Office (EAPO) has demonstrated remarkable progress in the first six months of…
The Intellectual Property Court recognized that a distributor’s seizure of a foreign trademark constituted unfair…
Patentica is grateful for the opportunity to join INTA 2025 Annual Meeting—the world’s premier intellectual…
The Republic of Kazakhstan has officially recognized the Eurasian Patent Organization (EAPO) as an International…
Rospatent refused registration of the trademark “Milk Wave’s” (Russian trademark application No. 2022775326) submitted by the…